Estados financieros detallados de Alector, Inc. (ALEC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Alector, Inc. registró ingresos de $21.0M en el último ejercicio fiscal, con un CAGR de 5 años del -0.1%.
Márgenes de los últimos 12 meses: margen bruto -360.9%, margen operativo -9.1%, margen neto -8.5%.
Al precio actual de $1.93, ALEC presenta beneficios negativos (P/E no significativo) y un ROE del -5.31%. La capitalización bursátil es de $214M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $416000 | $3.7M | $27.7M | $21.2M | $21.1M | $207.1M | $133.6M | $97.1M | $100.6M | $21.0M |
| Coste de Ventas | $13.7M | $29.9M | $73.0M | $100.5M | $156.9M | $189.4M | 0 | $8.8M | $185.9M | $9.7M |
| Beneficio Bruto | -$13.3M | -$26.2M | -$45.4M | -$79.3M | -$135.8M | $17.7M | $133.6M | $88.2M | -$85.4M | $11.4M |
| I+D | $13.7M | $29.9M | $73.0M | $100.5M | $156.9M | $189.4M | $210.4M | $192.1M | $209.2M | $123.1M |
| Generales y Administrativos | $1.9M | $6.5M | $11.9M | $33.9M | $59.4M | $55.0M | $61.0M | $56.7M | $57.4M | $54.0M |
| Gastos Operativos | $15.5M | $36.4M | $85.0M | $35.1M | $59.4M | $55.0M | $271.5M | $240.0M | $59.6M | $157.2M |
| Beneficio Operativo | -$15.1M | -$32.7M | -$57.3M | -$114.4M | -$195.2M | -$37.4M | -$137.8M | -$151.7M | -$145.0M | -$145.8M |
| EBITDA | -$14.9M | -$32.0M | -$56.3M | -$109.5M | -$187.9M | -$28.0M | -$121.6M | -$116.3M | -$110.1M | -$133.1M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$15.1M | -$32.5M | -$52.2M | -$105.4M | -$190.2M | -$36.3M | -$130.1M | -$125.2M | -$118.9M | -$142.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | $3.3M | $5.2M | $128000 | $168000 |
| Beneficio Neto | -$15.1M | -$32.5M | -$52.2M | -$105.4M | -$190.2M | -$36.3M | -$133.3M | -$130.4M | -$119.0M | -$142.9M |
| BPA | $-1.78 | $-0.63 | $-0.76 | $-1.62 | $-2.45 | $-0.45 | $-1.62 | $-1.56 | $-1.23 | $-1.39 |
| BPA Diluido | $-1.78 | $-0.63 | $-0.76 | $-1.62 | $-2.45 | $-0.45 | $-1.62 | $-1.56 | $-1.23 | $-1.39 |
| Acciones en Circulación (Diluidas) | $8.5M | $51.2M | $68.4M | $61.7M | $77.8M | $80.4M | $82.5M | $83.7M | $96.6M | $103.0M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $50.8M | $32.5M | $65.5M | $89.6M | $50.0M | $329.2M | $154.3M | $74.6M | $33.0M | $65.8M |
| Inversiones a Corto | 0 | 0 | $224.9M | $263.4M | $363.3M | $406.1M | $558.5M | $474.3M | $380.4M | $190.2M |
| Cuentas por Cobrar | $218000 | $200.2M | 0 | 0 | 0 | $7.4M | $2.6M | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $51.2M | $233.0M | $293.2M | $357.4M | $421.5M | $749.7M | $726.4M | $565.8M | $424.8M | $266.5M |
| Inmovilizado Material | $2.5M | $2.8M | $10.9M | $62.3M | $62.7M | $57.9M | $53.3M | $47.1M | $37.1M | $24.6M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $54.1M | $236.1M | $308.4M | $421.9M | $488.3M | $814.7M | $787.6M | $621.8M | $468.3M | $293.2M |
| Cuentas por Pagar | $1.2M | $1.1M | $126000 | $278000 | $3.0M | $4.7M | $4.2M | $3.8M | $2.2M | $1.7M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $366000 |
| Pasivos Corrientes | $1.5M | $27.4M | $13.0M | $62.0M | $68.1M | $139.6M | $93.8M | $177.9M | $125.1M | $69.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $9.4M | $9.3M |
| Pasivos Totales | $79.0M | $288.1M | $405.8M | $227.2M | $220.7M | $513.9M | $573.2M | $487.7M | $341.5M | $262.6M |
| Reservas | -$29.7M | -$62.2M | -$114.4M | -$219.8M | -$410.0M | -$446.4M | -$579.7M | -$710.1M | -$829.1M | -$972.1M |
| Patrimonio Neto | -$24.9M | -$52.0M | -$97.4M | $194.7M | $267.5M | $300.7M | $214.4M | $134.2M | $126.8M | $30.6M |
| Deuda Total | 0 | 0 | 0 | $48.0M | $51.3M | $47.6M | $43.3M | $38.9M | $42.5M | $36.2M |
| Deuda Neta | -$50.8M | -$32.5M | -$290.4M | -$305.0M | -$362.1M | -$687.6M | -$669.5M | -$509.9M | -$370.9M | -$219.8M |
| Capital Circulante | $49.7M | $205.6M | $280.1M | $295.5M | $353.4M | $610.2M | $632.6M | $387.9M | $299.8M | $196.9M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$15.1M | -$32.5M | -$52.2M | -$105.4M | -$190.2M | -$36.3M | -$133.3M | -$130.4M | -$119.0M | -$142.9M |
| Amortizaciones | $201000 | $680000 | $1.0M | $5.6M | $7.3M | $8.3M | $8.5M | $8.8M | $8.8M | $9.7M |
| Compensación en Acciones | $2.0M | $5.4M | $6.9M | $16.3M | $30.5M | $40.8M | $46.1M | $42.8M | $39.5M | $26.7M |
| Cambio en Capital Circulante | -$47000 | $8.7M | $174.4M | -$12.3M | -$15.2M | $283.7M | $59.5M | -$90.1M | -$147.0M | -$74.1M |
| Flujo de Caja Operativo | -$13.0M | -$17.8M | $127.5M | -$99.3M | -$166.7M | $298.6M | -$20.3M | -$184.2M | -$229.9M | -$184.0M |
| Inversiones (CapEx) | -$2.2M | -$801000 | -$1.9M | -$15.3M | -$5.0M | -$3.2M | -$4.1M | -$2.4M | -$1.3M | -$41000 |
| Adquisiciones | 0 | 0 | 0 | 0 | $100.0M | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$77000 | -$15000 | -$1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$15.2M | -$18.6M | $125.6M | -$114.6M | -$171.8M | $295.3M | -$24.4M | -$186.5M | -$231.2M | -$184.1M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +797.8% | +641.0% | -23.3% | -0.6% | +881.5% | -35.5% | -27.4% | +3.6% | -79.1% | |
| Crecimiento Beneficio Neto (anual) | -115.0% | -60.9% | -101.7% | -80.5% | +80.9% | -267.0% | +2.2% | +8.7% | -20.1% | |
| Crecimiento BPA (anual) | +64.6% | -20.6% | -113.2% | -51.2% | +81.6% | -260.0% | +3.7% | +21.2% | -13.0% | |
| Cambio en Acciones (anual) | +502.8% | +33.5% | -9.7% | +26.0% | +3.4% | +2.6% | +1.5% | +15.4% | +6.6% | |
| Crecimiento FCF (anual) | -21.8% | +776.2% | -191.2% | -49.9% | +271.9% | -108.3% | -663.1% | -23.9% | +20.4% | |
| Margen Bruto | -3187.0% | -700.8% | -163.9% | -373.8% | -643.5% | 8.5% | 100.0% | 90.9% | -84.9% | 54.1% |
| Margen Operativo | -3637.5% | -874.9% | -207.0% | -539.2% | -925.1% | -18.0% | -103.2% | -156.3% | -144.2% | -692.8% |
| Margen EBITDA | -3589.2% | -856.7% | -203.3% | -515.9% | -890.6% | -13.5% | -91.0% | -119.9% | -109.5% | -632.5% |
| Margen Neto | -3632.2% | -869.6% | -188.8% | -496.7% | -901.6% | -17.5% | -99.8% | -134.3% | -118.4% | -679.2% |
| Margen FCF | -3664.2% | -497.2% | 453.7% | -540.0% | -814.1% | 142.6% | -18.3% | -192.2% | -229.9% | -874.7% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -2.5% | -4.2% | -0.1% | -0.1% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-1.79 | $-0.36 | $1.84 | $-1.86 | $-2.21 | $3.67 | $-0.30 | $-2.23 | $-2.39 | $-1.79 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $8.5M | $51.2M | $68.4M | $61.7M | $77.8M | $80.4M | $82.5M | $83.7M | $96.6M | $103.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -531.04% |
| Rentabilidad sobre capital invertido | -67.56% |
| Rentabilidad sobre activos | -58.10% |
| Margen bruto | -360.92% |
| Margen operativo | -914.56% |
| Margen neto | -850.13% |
Salud financiera
| Deuda / Patrimonio | -3.29 |
| Ratio corriente | 5.26 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -5.04 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -10.11 | -28.57 | -23.68 | -10.64 | -6.18 | -45.89 | -5.70 | -5.12 | -1.54 | -1.12 |
| P/VC | -6.14 | -17.72 | -12.63 | 5.46 | 4.40 | 5.52 | 3.55 | 4.98 | 1.44 | 5.24 |
| P/V | 367.68 | 246.86 | 44.46 | 50.13 | 55.76 | 8.02 | 5.70 | 6.88 | 1.82 | 7.63 |
| Margen Bruto | -3187.0% | -700.8% | -163.9% | -373.8% | -643.5% | 8.5% | 100.0% | 90.9% | -84.9% | 54.1% |
| Margen Operativo | -3637.5% | -874.9% | -207.0% | -539.2% | -925.1% | -18.0% | -103.2% | -156.3% | -144.2% | -692.8% |
| Margen Neto | -3632.2% | -869.6% | -188.8% | -496.7% | -901.6% | -17.5% | -99.8% | -134.3% | -118.4% | -679.2% |
Empresas relacionadas: ABOS · APLT · CRBP · FATE · IRD · MOLN · NKTX
Explorar sector: Healthcare · Biotechnology
Más secciones de ALEC: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones